GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beverly JCG Ltd (SGX:9QX) » Definitions » EPS (Diluted)

Beverly JCG (SGX:9QX) EPS (Diluted) : S$-0.01 (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Beverly JCG EPS (Diluted)?

Beverly JCG's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was S$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was S$-0.01.

Beverly JCG's EPS (Basic) for the three months ended in Mar. 2024 was S$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was S$-0.01.

Beverly JCG's EPS without NRI for the three months ended in Mar. 2024 was S$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was S$-0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 20.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 23.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 32.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Beverly JCG's highest 3-Year average EPS without NRI Growth Rate was 68.60% per year. The lowest was -310.20% per year. And the median was 20.60% per year.


Beverly JCG EPS (Diluted) Historical Data

The historical data trend for Beverly JCG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beverly JCG EPS (Diluted) Chart

Beverly JCG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.02 -0.01 -0.01 -0.01

Beverly JCG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Beverly JCG's EPS (Diluted)

For the Medical Care Facilities subindustry, Beverly JCG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beverly JCG's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beverly JCG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Beverly JCG's PE Ratio falls into.



Beverly JCG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Beverly JCG's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.218-0)/449.412
=-0.00

Beverly JCG's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.597-0)/584.711
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was S$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beverly JCG  (SGX:9QX) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Beverly JCG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Beverly JCG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Beverly JCG (SGX:9QX) Business Description

Traded in Other Exchanges
N/A
Address
600 North Bridge Road, No. 06-02 Parkview Square, Singapore, SGP, 068914
Beverly JCG Ltd provides aesthetics medical and healthcare services. The company operates in three business segments. The Trading and distribution segment involves steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron, and steel foundries, and aluminum smelters. The aesthetic medical segment involves the provision of aesthetic medicine, beauty, and wellness services in Asia. The investment segment involves investment holding, provision of management services, marketing, distribution, and related services. Geographically, the firm operates in Singapore, Malaysia, Taiwan, & China.

Beverly JCG (SGX:9QX) Headlines

No Headlines